GLPwatch
Papers (12034)
Page 111 of 201, ranked by citation count.
- Regression of diabetic macular edema after subcutaneous exenatide.
- A Review of Oral Semaglutide Available Evidence: A New Era of Management of Diabetes with Peptide in a Pill Form.
- Efficacy of liraglutide on metabolic and reproductive outcomes in women with polycystic ovary syndrome: A systematic review and meta-analysis.
- [Effects of GLP-1 Agonist Exenatide on Cardiac Diastolic Function and Vascular Endothelial Function in Diabetic Patients].
- Effects of liraglutide on ANP secretion and cardiac dynamics.
- Liraglutide chronic treatment prevents development of tolerance to antiseizure effects of diazepam in genetically epilepsy prone rats.
- Hemodynamic effect of a single dose of glucagon-like peptide 1 receptor (GLP-1R) agonist liraglutide in patients with diabetic kidney disease.
- Is it safe to acutely discontinue insulin therapy in patients with chronic hyperglycaemia starting GLP-1R agonists?
- The Efficacy of Semaglutide on Hypothalamic Obesity Caused by Craniopharyngioma Surgery.
- Tirzepatide in Hispanic/Latino Patients With Type 2 Diabetes: A Subgroup Analysis of the SURPASS Program.
- A meta-analysis of the incidence of acne vulgaris in patients treated with GLP-1 agonists.
- Glucagon-like peptide-1 analog liraglutide reduces fat deposition in chicken adipocytes.
- Novel antidiabetic nutrients identified by in vivo screening for gastric secretion and emptying regulation in rats.
- Medication adherence to sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists: A meta-analysis.
- Semaglutide Treatment in Adult-Onset Autoimmune Diabetes: A Case Study With Long-Term Follow-Up and Periodic Evaluation of Beta-Cell Function.
- GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization.
- Nutrition Strategies for Next-Generation Incretin Therapies: A Systematic Scoping Review of the Current Evidence.
- Allodynia (skin tenderness) associated with semaglutide: A case series.
- Effect of semaglutide versus placebo on cardiorenal outcomes by prior cardiovascular disease and baseline body mass index: Pooled post hoc analysis of SUSTAIN 6 and PIONEER 6.
- Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis.
- Diurnal glucose exposure profiles of patients treated with lixisenatide before breakfast or the main meal of the day: An analysis using continuous glucose monitoring.
- [Lixisenatide in patients with type 2 diabetes and obesity: Beyond glycaemic control].
- Targeting obesity for therapeutic intervention in heart failure patients.
- Pancreatic safety of newer incretin-based therapies: are the "-tides" finally turning?
- Tirzepatide Induces Ferroptosis in Glioblastoma Cell Lines via the SOX2/SLC7A11 Axis: A Potential Therapeutic Strategy for Glioma Treatment.
- Liraglutide reduces attenuation coefficient as a measure of hepatic steatosis during 16 weeks' treatment in nondiabetic obese patients: A pilot trial.
- Rare genetic forms of obesity in childhood and adolescence: A narrative review of the main treatment options with a focus on innovative pharmacological therapies.
- Systematic Design of Trypsin Cleavage Site Mutated Exendin4-Cysteine 1, an Orally Bioavailable Glucagon-Like Peptide-1 Receptor Agonist.
- Liraglutide-associated depression in a patient with type 2 diabetes: A case report and discussion.
- Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review.
- New Radiolabeled Exendin Analogues Show Reduced Renal Retention.
- GLP-1/GIP dual agonist tirzepatide alleviates mice model of Parkinson's disease by promoting mitochondrial homeostasis.
- Glycaemic efficacy of an expanded dose range of dulaglutide according to baseline glycated haemoglobin (HbA1c) subgroup: Post hoc analysis of AWARD-11.
- Semaglutide, a newly available glucagon-like peptide receptor agonist, shows remarkable favorable effects in hemodialysis patients with obesity and Type 2 diabetes.
- Tirzepatide and the new era of twincretins for diabetes.
- Energy balance and obesity: the emerging role of glucagon like peptide-1 receptor agonists.
- Body weight loss with oral semaglutide is mediated predominantly by effects other than gastrointestinal adverse events in patients with type 2 diabetes: A post hoc analysis.
- Two novel solvent system compositions for protected synthetic peptide purification by centrifugal partition chromatography.
- Analysis of the effect of liraglutide on glycemic variability in patients with type 2 diabetes.
- An Uncommon Case of Dulaglutide-Related Morbilliform Drug Eruption.
- Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes.
- Comparison of nephron-protective effects of enalapril and GLP analogues (exenatide) in diabetic nephropathy.
- Novel therapies for the management of type 2 diabetes mellitus: Part 2. Addressing the incretin defect in the clinical setting in 2013.
- Protective effects of melatonin and glucagon-like peptide-1 receptor agonist (liraglutide) on gastric ischaemia-reperfusion injury in high-fat/sucrose-fed rats.
- The Clinical Use of a Fixed-Dose Combination of Insulin Degludec and Liraglutide (Xultophy 100/3.6) for the Treatment of Type 2 Diabetes.
- Real-world effectiveness of Semaglutide treatment on weight loss maintenance after weight loss in patients with obesity or overweight and diabetes.
- Efficacy and Safety of Oral Semaglutide in the Treatment of Type 2 Diabetes: A Meta-Analysis.
- The impact of GLP-1 receptor agonist shortages on glycaemic Control: Findings from an Australian specialist diabetes clinic.
- Oral Semaglutide (Rybelsus) for the Treatment of Type 2 Diabetes Mellitus.
- Pharmacological characterization and antidiabetic activity of a long-acting glucagon-like peptide-1 analogue conjugated to an antithrombin III-binding pentasaccharide.
- Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity.
- Remission of insulin resistance in type 2 diabetic patients after gastric bypass surgery or exenatide therapy.
- Pancreatic Safety of Tirzepatide and Its Effects on Islet Cell Function: A Systematic Review and Meta-Analysis.
- Causes and consequences of discontinuation of GLP1RAs or tirzepatide.
- Albiglutide for the management of type 2 diabetes.
- Mazdutide: First Approval.
- GLP-1R activation alters performance in cognitive tasks in a sex-dependent manner.
- Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial.
- Anti-obesity drug also protects against heart disease - what happens next?
- Efficacy and safety of adding liraglutide to existing insulin regimens in Japanese patients with type 2 diabetes mellitus: A post-hoc analysis of a phase 3 randomized clinical trial.